Optimization of Antisense Chimeric Oligonucleotides Containing α- and β-Anomeric Deoxynucleotides

References

• Giles , R. V. and Tidd , D. M. 1992 . Anti-Cancer Drug Design , 7 : 37
   PubMedGoogle Scholar
• Monia , B. P. , Lesnik , E. A. , Gonzalez , C. , Lima , W. F. , McGee , D. , Guinosso , C. J. , Kawasaki , A. M. , Cook , P. D. and Freier , S. M. 1993 . J. Biol. Chem. , 268 : 14514
   PubMed Web of Science ®Google Scholar
• Gagnor , C. , Rayner , B. , Leonetti , J.-P. , Imbach , J.-L. and Lebleu , B. 1989 . Nucleic Acids Res. , 17 : 5107
   PubMed Web of Science ®Google Scholar
• Morvan , F. , Porumb , H. , Degols , G. , Lefebvre , I. , Pompon , A. , Sproat , B. S. , Rayner , B. , Malvy , C. , Lebleu , B. and Imbach , J.-L. 1993 . J. Med. Chem. , 36 : 280
   PubMed Web of Science ®Google Scholar
• Vichier-Guerre , S. , Pompon , A. , Lefebvre , I. and Imbach , J.-L. 1994 . Antisense Res. Dev. , 4 : 9 – 18 .
   PubMedGoogle Scholar
• Pompon , A. , Lefebvre , I. and Imbach , J.-L. 1992 . Biochem. Pharmacol. , 43 : 1769
   PubMed Web of Science ®Google Scholar